Researcher
Peter Vandenabeele
- Keywords (Ghent University):Cell death and inflammation
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Ghent University):Biophysics, Molecular and cell biology, Laboratory medicine, Microbiology, Systems biology, Plant biology, Medicinal and biomolecular chemistry, Molecular and cell biology not elsewhere classified
Affiliations
- Vandenabeele Lab (Research group)
Responsible
From1 Jan 2017 → Today - Board of Governors/Executive Board (Administrative office)
Member
From1 Oct 2012 → Today - Department of Biomedical molecular biology (Department)
Member
From1 Oct 1993 → Today - Department of Plant Biotechnology and Bioinformatics (Department)
Member
From1 Jan 1993 → 30 Sep 1993
Projects
1 - 10 of 69
- Role and mechanism of caspase-3/7 as checkpoint for intestinal inflammation and regenerationFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Role of ZBP1 signalling in doxorubicin-mediated anticancer immunity and drug-induced pathologyFrom1 Oct 2023 → TodayFunding: BOF - projects
- Stichting tegen Kanker: Advanced technology equipment: Small Animal Radiation Therapy platform (SmART+)From1 Jul 2022 → TodayFunding: Foundations, funds and other with scientific goal
- SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomicsFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Mechanisms of ferroptosis mediated immunoregulationFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Cell Death Regulation and Role in Infection and Inflammatory DiseasesFrom1 Jan 2022 → TodayFunding: FWO EOS
- Investigating Trans-Generational Training Networks in Central Africa: A Multi-Layered Analysis of Pottery TechnologyFrom1 Oct 2021 → TodayFunding: FWO senior postdoctoral fellowship
- Improving cancer therapy by modulating cell death and the microbiome in the gutFrom1 Mar 2021 → 29 Feb 2024Funding: Foundations, funds and other with scientific goal
- Autophagy in inflammation and inflammatory disorders (ATLANTIS), from basic insights to experimental therapyFrom1 Jan 2021 → TodayFunding: BOF - iBOF
- Investigating the immunoregulatory properties of ferroptosis in experimental cancer modelsFrom1 Nov 2020 → TodayFunding: FWO fellowships
Publications
11 - 20 of 306
- Tyramide signal amplification for the immunofluorescent staining of ZBP1-dependent phosphorylation of RIPK3 and MLKL after HSV-1 infection in human cells(2022)
Authors: Josephine Nemegeer, Kelly Lemeire, Peter Vandenabeele, Jonathan Maelfait
- Targeting ferroptosis protects against experimental (multi)organ dysfunction and death(2022)
Authors: Samya Van Coillie, Emily Van San, Ines Goetschalckx, Bartosz Wiernicki, Banibrata Mukhopadhyay, Wulf Tonnus, Ria Roelandt, Catalina Dumitrascu, Ludwig Lamberts, Geert Dams, et al.
- Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer(2022)
Authors: Teodora-Eugenia Oltean, Kelly Lemeire, Marnik Vuylsteke, Hannelore Denys, Peter Vandenabeele, Sandy Adjemian Catani
- Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state(2022)
Authors: Farzaneh Ghazavi, Jelle Huysentruyt, Stephanie Kourula, Sofie Martens, Tim Wartewig, Tatyana Divert, Ria Roelandt, Bastian Popper, Andreas Hiergeist, Peter Tougaard, et al.
- Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity(2022)
Authors: Bartosz Wiernicki, Sophia Maschalidi, Jonathan Pinney, Sandy Adjemian Catani, Tom Vanden Berghe, Kodi Ravichandran, Peter Vandenabeele
- Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies(2022)
Authors: Teodora-Eugenia Oltean, Lorena Ibanez, Tatyana Divert, Tine Ysenbaert, Hannelore Van Eeckhoutte, Michael Schotsaert, Jonathan Maelfait, Nozomi Takahashi, Peter Vandenabeele
- Novel iron oxide nanoparticles induce ferroptosis in a panel of cancer cell lines(2022)
Authors: Roberto Fernandez-Acosta, Claudia Iriarte-Mesa, Daniel Alvarez-Alminaque, Behrouz Hassannia, Bartosz Wiernicki, Alicia M. Diaz-Garcia, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L. Pardo Andreu
- Bacillus anthracis induces NLRP3 inflammasome activation and caspase-8-mediated apoptosis of macrophages to promote lethal anthrax(2022)
Authors: Filip Van Hauwermeiren, Nina Van Opdenbosch, Hanne Van Gorp, Nathalia de Vasconcelos, Geert van Loo, Peter Vandenabeele, Thirumala-Devi Kanneganti, Mohamed Lamkanfi
- Viral manipulation of host cell necroptosis and pyroptosis(2022)
Authors: Simon Verdonck, Josephine Nemegeer, Peter Vandenabeele, Jonathan Maelfait
Pages: 593 - 605 - ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation(2022)
Authors: Richard de Reuver, Simon Verdonck, Evelien Dierick, Josephine Nemegeer, Eline Hessmann, Sadeem Ahmad, Maude Jans, Gillian Blancke, Filip Van Nieuwerburgh, Alexander Botzki, et al.
Pages: 784 - 789
Patents
1 - 6 of 6
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)